Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELU) Equity Ratio (2020 - 2025)

Celularity has reported Equity Ratio over the past 6 years, most recently at 0.18 for Q3 2025.

  • Quarterly results put Equity Ratio at 0.18 for Q3 2025, down 231.15% from a year ago — trailing twelve months through Sep 2025 was 0.18 (down 231.15% YoY), and the annual figure for FY2024 was 0.07, down 76.6%.
  • Equity Ratio for Q3 2025 was 0.18 at Celularity, up from 0.21 in the prior quarter.
  • Over the last five years, Equity Ratio for CELU hit a ceiling of 0.5 in Q4 2022 and a floor of 5.05 in Q2 2021.
  • Median Equity Ratio over the past 5 years was 0.21 (2022), compared with a mean of 0.19.
  • Biggest five-year swings in Equity Ratio: soared 119.47% in 2021 and later crashed 231.15% in 2025.
  • Celularity's Equity Ratio stood at 0.24 in 2021, then skyrocketed by 106.58% to 0.5 in 2022, then crashed by 42.6% to 0.28 in 2023, then tumbled by 76.6% to 0.07 in 2024, then crashed by 364.09% to 0.18 in 2025.
  • The last three reported values for Equity Ratio were 0.18 (Q3 2025), 0.21 (Q2 2025), and 0.04 (Q1 2025) per Business Quant data.